Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease.

Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease. Abstract Text:

    alka kriplaniAlka Kriplani,bhawna malhotra singhBhawna Malhotra Singh,kavita mandalKavita Mandal,

    Intrauterine blood transfusion is the mainstay of treatment of fetal rhesus hemolytic anemia with optimal perinatal outcome. Postnatal immunoglobulin therapy has been successfully used in the management of alloimmunized neonates and has shown to decrease the need for exchange transfusion. We report the first case series of fetal immunoglobulin therapy in the antenatal management of severe Rh incompatibility.

    Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease. Publishing Authors By Initials

    a kriplaniA Kriplani,b malhotra singhB Malhotra Singh,k mandalK Mandal,

    For similar diagnosis: prognosis: treatment outcome research abstracts see: diagnosis: prognosis: treatment outcome research

    PUBMED ID PMID:

    MEDLINE DATE:

    Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Gynecologic and obstetric investigation

    VOLUME: 63

    Page Numbers: 176-80

    Journal Abbreviation: Gynecol. Obstet. Invest.

    ISSN: 0378-7346

    DAY: 1

    MONTH: 12

    YEAR: 2006

    Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7900587

    Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease. Keywords Mesh Terms:

    KEYWORDS: Treatment Outcome

    MESH TERMS: therapy

    Chemical & Substance for Abstract: Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease. Information

    Substance Name: Isoantibodies

    Registry Number: 0

    Grant and Affiliation Information for Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease.

    AFFILIATION: Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India.

    Country: Switzerland

    Switzerland Research PublicationSwitzerland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Gynecol Obstet Invest

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News